Factors Affecting Long-Term Outcomes and Quality of Life of Patients with Pituitary Adenoma After Endoscopic Endonasal Transsphenoidal Surgery (EETS) Using the SF-36 Questionnaire (Indonesian Version)
DOI:
https://doi.org/10.15605/jafes.041.02.6141Keywords:
pituitary adenoma, quality of life, EETS, SF-36, hormonal deficiencyAbstract
Objective. To evaluate the quality of life (QoL) of patients with pituitary adenoma following Endoscopic Endonasal Transsphenoidal Surgery (EETS) and identify factors influencing long-term outcomes.
Methodology. A cross-sectional study was conducted at the National Brain Center Hospital, Indonesia. Secondary data were obtained from medical records and the pituitary registry, while primary data were collected through patient interviews using the validated Indonesian version of the SF-36 questionnaire. Statistical analyses included univariate, bivariate, and multivariate linear regression with the backward method to identify independent predictors of QoL.
Results. Among 90 patients (45 males, 45 females), visual disturbances (85.6%) and hormonal deficiencies (93.3%) were common. Most had macroadenomas (95.6%) and received combined EETS and medical therapy (62.2%). Physical component scores (PCS) exceeded mental component scores (MCS). The highest domain scores were in physical functioning and role-emotional functioning; vitality and mental health had the lowest scores. Gender was significantly associated with four QoL domains, and hormonal deficiency affected the role-emotional domain. Multivariate analysis identified gender and hormonal deficiency as predictors of MCS (R² = 74%); no factors significantly influenced PCS.
Conclusion. Postoperative QoL after EETS is generally good in physical aspects but suboptimal in mental health. Gender and hormonal deficiency affect mental QoL, highlighting the need for holistic, long-term care strategies.
Downloads
References
1. Daly AF, Beckers A. The epidemiology of pituitary adenomas. Endocrinol Metab Clin North Am. 2020;49(3):347-55. https://pubmed.ncbi.nlm.nih.gov/32741475 https://doi.org/10.1016/j.ecl.2020.04.002
2. Karvandi E, Hanrahan JG, Khan DZ, et al. A patient-reported outcome measure for patients with pituitary adenoma undergoing transsphenoidal surgery. Pituitary. 2022;25(4):673-83. https://pubmed.ncbi.nlm.nih.gov/35838913 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345822 https://doi.org/10.1007/s11102-022-01251-x
3. Salari N, Ghasemi H, Fatahian R, et al. The global prevalence of primary central nervous system tumors: A systematic review and meta-analysis. Eur J Med Res. 2023;28(1):39. https://pubmed.ncbi.nlm.nih.gov/36670466 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854075 https://doi.org/10.1186/s40001-023-01011-y
4. Shafiq I, Anastasopoulou C. Pituitary adenoma. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2026.
5. Aninditha T, Pratama PY, Sofyan HR, et al. Adults brain tumor in Cipto Mangunkusumo General Hospital: A descriptive epidemiology. Rom J Neurol. 2021;20(4):480-4. DO:10.37897/RJN.2021.4.13
6. Johnson MD, Woodburn CJ, Vance ML. Quality of life in patients with a pituitary adenoma. Pituitary. 2003;6(2):81-7. https://pubmed.ncbi.nlm.nih.gov/14703017 https://doi.org/10.1023/b:pitu.0000004798.27230.ed
7. Nitihapsari GY, Prihatningtias R. Optical coherence tomography predicts visual recovery of patients with pituitary adenoma following surgery in Dr Kariadi Hospital Semarang. Opthalmol Indones. 2024;49(S1):10-6. https://doi.org/10.35749/tfztq864
8. Kementerian Kesehatan Republik Indonesia. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tumor Otak. Jakarta, Indonesia: Kementerian Kesehatan Republik Indonesia; 2020. https://rsudhaulussymaluku.com/unduh/4
9. Wang L, Liu S, Zheng J, Li R, Xing Z. Contributing factors to postoperative surgical site infections in pituitary neuroendocrine tumors undergoing endonasal transsphenoidal resection. Sci Rep. 2025;15(1):2995. https://pubmed.ncbi.nlm.nih.gov/39848981 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11757733 https://doi.org/10.1038/s41598-025-86567-x
10. Chumnanvej S, Pillai BM, Chalongwongse S, Suthakorn J. Endonasal endoscopic transsphenoidal approach robot prototype: A cadaveric trial. Asian J Surg. 2021;44(1):345-51. https://pubmed.ncbi.nlm.nih.gov/32951962 https://doi.org/10.1016/j.asjsur.2020.08.011
11. Suchan M, Kaliarik L, Zeliznak V, Skalova M, Kollova A, Banocy J. Advantages of endoscopic transsphenoidal pituitary gland tumor surgery. Bratisl Med J. 2024;125(1):38-41. https://pubmed.ncbi.nlm.nih.gov/38041844 https://doi.org/10.4149/BLL_2024_007
12. Lobatto DJ, van den Hout WB, Zamanipoor Najafabadi AH, et al. Healthcare utilization and costs among patients with non-functioning pituitary adenomas. Endocrine. 2019;64(2):330-40. https://pubmed.ncbi.nlm.nih.gov/30903570 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531397 https://doi.org/10.1007/s12020-019-01847-7
13. Tabuzo MMB, Hernandez MALU, Chua AE, Maningat PD, Chiu HHC, Jamora RDG. Pituitary adenoma in the Philippines: A scoping review on the treatment gaps, challenges, and current state of care. Med Sci (Basel). 2024;12(1):16. https://pubmed.ncbi.nlm.nih.gov/38535157 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10972485 https://doi.org/10.3390/medsci12010016
14. Pereira AM. Long-term effects of treatment of pituitary adenomas. Handb Clin Neurol. 2014;124:361-71. https://pubmed.ncbi.nlm.nih.gov/25248599 https://doi.org/10.1016/B978-0-444-59602-4.00024-1
15. Joustra GE, ten Dam E, Vermeulen KM, Korsten-Meijer AGW, Appelman APA, Feijen RA. Prospective evaluation of multidimensional health-related quality of life after endoscopic endonasal surgery for pituitary adenomas using the endoscopic endonasal sinus and skull base surgery questionnaire. Laryngoscope Investig Otolaryngol. 2023;8(1):7-15. https://pubmed.ncbi.nlm.nih.gov/36846430 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948581 https://doi.org/10.1002/lio2.1004
16. Salim S, Yamin M, Alwi I, Setiati S. Validity and reliability of the Indonesian version of SF-36 quality of life questionnaire on patients with permanent pacemakers. Acta Med Indones. 2017;49(1):10-6. https://pubmed.ncbi.nlm.nih.gov/28450649
17. Arovah NI, Heesch KC. Verification of the reliability and validity of the Short Form-36 scale in Indonesian middle-aged and older adults. J Prev Med Public Health. 2020;53(3):180-8. https://pubmed.ncbi.nlm.nih.gov/32498143 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280813 https://doi.org/10.3961/jpmph.19.324
18. de Silva NL, Dissanayake H, Kalra S, Meeran K, Somasundaram NP, Jayasena CN. Global barriers to accessing off-patent endocrine therapies: A renaissance of the orphan disease? J Clin Endocrinol Metab. 2024;109(5):e1379-88. https://pubmed.ncbi.nlm.nih.gov/37846800 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11031238 https://doi.org/10.1210/clinem/dgad610
19. Asa SL, Mete O, Perry A, Osamura RY. Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol. 2022;33(1):6-26. https://pubmed.ncbi.nlm.nih.gov/35291028 https://doi.org/10.1007/s12022-022-09703-7
20. Melmed S, Kaiser UB, Lopes MB, , et al. Clinical biology of the pituitary adenoma. Endocr Rev. 2022;43(6):1003-37. https://pubmed.ncbi.nlm.nih.gov/35395078 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695123 https://doi.org/10.1210/endrev/bnac010
21. Perkumpulan Endokrinologi Indonesia. Konsensus Pendekatan Diagnosis Adenoma Hipofisis. Jakarta, Indonesia: Perkumpulan Endokrinologi Indonesia; 2024. https://pbperkeni.or.id/uncategorized/konsensus-pendekatan-diagnosis-adenoma-hipofisis_final-revision-1-okt-2024-1
22. Vega-Beyhart A, Enriquez-Estrada VM, Bello-Chavolla OY, et al. Quality of life is significantly impaired in both secretory and non-functioning pituitary adenomas. Clin Endocrinol (Oxf). 2019;90(3):457-67. https://pubmed.ncbi.nlm.nih.gov/30548674 https://doi.org/10.1111/cen.13915
23. Uvelius E. Pituitary adenoma: Aspects of outcome after surgical intervention. 2021.
24. Kołtowska-Häggström M, Mattsson AF, Monson JP, et al. Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life? Eur J Endocrinol. 2006;155(1):109-19. https://pubmed.ncbi.nlm.nih.gov/16793956 https://doi.org/10.1530/eje.1.02176
25. Capatina C, Christodoulides C, Fernandez A, et al. Current treatment protocols can offer a normal or near-normal quality of life in the majority of patients with non-functioning pituitary adenomas. Clin Endocrinol (Oxf). 2013;78(1):86-93. https://pubmed.ncbi.nlm.nih.gov/22640418 https://doi.org/10.1111/j.1365-2265.2012.04449.x
26. Molitch ME. Diagnosis and treatment of pituitary adenomas: A review. JAMA. 2017;317(5):516-24. https://pubmed.ncbi.nlm.nih.gov/28170483 https://doi.org/10.1001/jama.2016.19699
27. Banskota S, Adamson DC. Pituitary adenomas: From diagnosis to therapeutics. Biomedicines. 2021;9(5):494. https://pubmed.ncbi.nlm.nih.gov/33946142 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146984 https://doi.org/10.3390/biomedicines9050494
28. Zhang X, Li Y, Zhang D, Zhong Y, Li T. Fatigue and its contributing factors in Chinese patients with primary pituitary adenomas. J Oncol. 2023;2023:9876422. https://pubmed.ncbi.nlm.nih.gov/36968639 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033214 https://doi.org/10.1155/2023/9876422
29. Behzadi F, Pickles AC, Ciecierska SS, Choe S, Prabhu VC, Germanwala AV. Patients at greatest risk of missing initial 1-year follow-up after pituitary adenoma resection. World Neurosurg. 2024;189:e1092-7. https://pubmed.ncbi.nlm.nih.gov/39032634 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11971957 https://doi.org/10.1016/j.wneu.2024.07.091
30. Osorio RC, Pereira MP, Joshi RS, et al. Socioeconomic predictors of case presentations and outcomes in 225 nonfunctional pituitary adenoma resections. J Neurosurg. 2022;136(5):1325-36. https://pubmed.ncbi.nlm.nih.gov/34598141 https://doi.org/10.3171/2021.4.JNS21907
31. Donkor A, Atuwo-Ampoh VD, Yakanu F, et al. Financial toxicity of cancer care in low- and middle-income countries: A systematic review and meta-analysis. Support Care Cancer. 2022;30(9):7159-90. https://pubmed.ncbi.nlm.nih.gov/35467118 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385791 https://doi.org/10.1007/s00520-022-07044-z
32. Castle-Kirszbaum M, McCormack A, Kam J, King J, Wang YY, Goldschlager T. Quality of life in non-functioning pituitary adenoma: A systematic review. Neurosurg Rev. 2024;47(1):867. https://pubmed.ncbi.nlm.nih.gov/39578273 https://doi.org/10.1007/s10143-024-03126-0
33. Joustra GE, van Rhee NF, den Heijer MC, et al. Very long-term follow-up of multidimensional health-related quality of life after endoscopic endonasal surgery for pituitary adenomas: A prospective cohort study. Head Neck. 2026;48(4):1088-96. https://pubmed.ncbi.nlm.nih.gov/41312616 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12972636 https://doi.org/10.1002/hed.70103
34. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-70. https://pubmed.ncbi.nlm.nih.gov/6880820 https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
35. Gil Z, Abergel A, Spektor S, , et al. Quality of life following surgery for anterior skull base tumors. Arch Otolaryngol Head Neck Surg. 2003;129(12):1303-09. https://pubmed.ncbi.nlm.nih.gov/14676156 https://doi.org/10.1001/archotol.129.12.1303
36. Karabatsou K, O'Kelly C, Ganna A, Dehdashti AR, Gentili F. Outcomes and quality of life assessment in patients undergoing endoscopic surgery for pituitary adenomas. Br J Neurosurg. 2008;22(5):630-5. https://pubmed.ncbi.nlm.nih.gov/18686060 https://doi.org/10.1080/02688690802220379
37. Tanemura E, Nagatani T, Aimi Y, et al. Quality of life in nonfunctioning pituitary macroadenoma patients before and after surgical treatment. Acta Neurochir (Wien). 2012;154(10):1895–1902. https://doi.org/10.1007/s00701-012-1473-3
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Novie Rahmawati Zirta, Tri Juli Edi Tarigan, Rudi Putranto, Murdani Abdullah, Budiman, Arya Govinda Roosheroe, Edy Rizal Wahyudi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The full license text is available at: http://creativecommons.org/licenses/by-nc/3.0/legalcode.
To request permission to translate, reproduce, download, or use articles or images for commercial reuse or business purposes from the Journal of the ASEAN Federation of Endocrine Societies (JAFES), kindly complete the Permission Request for Use of Copyrighted Material Form and email jafes@asia.com or jafes.editor@gmail.com.
A written agreement will be issued to the requester once permission has been granted.
